ENTPD1 and neoplasm: Inhibition of CD39-mediated hydrolysis of ATP and ADP has the potential to promote antitumor immunity by inducing tumor accumulation of immunostimulatory ATP and reducing the formation of immunosuppressive adenosine (1, 4, 10).